# Alpha Wave Global

> Alpha Wave Global is a VC fund backing Financial Services. See 116 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 116
- Last investment: Oct 2024
- Lead investor: 59%
- Last fund: Dec 2021
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/alphawaveglobal
- Website: https://www.falconedgecap.com

Alpha Wave Global is a VC fund in New York focused on Financial Services and Artificial Intelligence. Alpha Wave is an investment company that has three main verticals; private equity, private credit, and public markets. The objective of the private equity partnerships is to invest in best-in-class venture and growth stage companies and endeavors to be helpful, long-term partners to these exceptional founders and management teams; credit, whichincludes direct private lending to businesses looking for funding solutions; and public markets in an uncorrelated strategy.Alpha Wave has offices in New York, Miami, London, Monaco, Madrid, Abu Dhabi, Tel Aviv, Bangalore, and Sydney.

## Contacts

5 contacts available for Alpha Wave Global. Shizune tracks 5 team members at Alpha Wave Global. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/falcon-edge-capital-2?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $4.5M–$70M |
| Series B | $17M–$135M |
| Series C | $28M–$135M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Financial Services | 13 | 11% |
| Artificial Intelligence | 11 | 9% |
| FinTech | 10 | 9% |
| Software | 10 | 9% |
| E-Commerce | 10 | 9% |

136 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 26 | 22% |
| Series A | 24 | 21% |
| Series C | 13 | 11% |
| Series E | 8 | 7% |
| Seed | 7 | 6% |

16 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| India | 41 | 35% |
| United States | 24 | 21% |
| Singapore | 6 | 5% |
| Israel | 2 | 2% |
| Indonesia | 2 | 2% |

8 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Chris Dimitropoulos | Managing Director | 10 | https://shizune.co/investors/profile/chris-dimitropoulos-956b |
| Mohammad MM | Testing | 0 | https://shizune.co/investors/profile/mohamed-nawaz |
| Navroz Udwadia | Co-Founder and Partner | 61 | https://shizune.co/investors/profile/navroz-d-udwadia |
| Rick Gerson | Co-Founder, Chairman & Chief Investment Officer | 23 | https://shizune.co/investors/profile/rick-gerson-c5aa |
| Ryan Khoury | Co-Founder and Partner | 1 | https://shizune.co/investors/profile/ryan-khoury |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Mstack Chemicals | A B2B platform connecting global companies for cost-effective chemical sourcing. | $40M | Series A | Oct 03, 2024 |  |
| Marea Therapeutics | Marea Therapeutics is a clinical-stage biotechnology firm that uses the most recent advancements in human genetics to create first-in-class, next-generation medications for cardiometabolic illnesses. | $190M | Series B | Jun 18, 2024 |  |
| Stanza Living | Stanza Living is a high-quality, shared living concept which is seeking to disrupt the multi-billion-dollar student housing and co-living market in India by putting the new-age migrant consumer at the heart of the product and service design, development, and execution. At 55,000 beds under management, across 14 cities, it is India's largestshared living company. As a full-stack, end-to-end managed, tech-enabled operator, Stanza Living is focused on delivering a hassle-free daily living experience to consumers. The company is backed by global investors like Equity International, Falcon Edge Capital, Sequoia India, Matrix, Accel Partners, and Alteria Capital.Stanza Living was founded in 2017 and is headquartered in New Delhi, India. | $13.2M | Venture - Series Unknown | May 18, 2024 |  |
| Mitra Chem | Mitra Chem operates as a lithium-ion battery materials manufacturer. It innovates and commercializes iron-based cathode materials to enable mass-market electrification in transportation and energy storage. The company is driven to industrialize these cathodes in purpose-built inflation reduction act-compliant facilities. |  | Series B | May 13, 2024 |  |
| LENZ Therapeutics | LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. | $53.5M | Post-IPO Equity | Mar 21, 2024 |  |
| Mswipe Technologies | Mswipe is an independent mobile POS merchant acquirer and network provider. The company believes in serving the smallest of merchants. India currently has 12-15 million SMEs and mobile POS is the only channel that can efficiently link these SMEs to mainstream financial services and digital commerce.Today less than 500,000 SMEs have any type ofPOS. Mswipe aims to provide seamless mobile POS solutions to such merchants across India and create India’s largest financial services platform for SMEs. | $20M | Venture - Series Unknown | Feb 27, 2024 |  |
| gamma | gamma operates as a modern media and music company created to revolutionize the way artists create, distribute, and monetize their content and brand. | $100M | Private Equity | Feb 01, 2024 |  |
| Moonwalk Biosciences | Moonwalk Biosciences is a genomic medicine startup that aims to provide a new class of precision epigenetic therapeutics. The company is working on the development of a profiling and engineering technology platform that, with the help of advanced artificial intelligence prediction, provides a comprehensive view of the epigenome in health anddisease, allowing healthcare providers to take a fresh look at how therapies are discovered and developed. | $57M | Series A | Jan 04, 2024 |  |
| HI-Bio | Human Immunology Biosciences is a biotechnology company that focuses on developing therapies for immune-mediated diseases. The company's lead product, felzartamab, is a fully human anti-CD38 monoclonal antibody that has been shown in clinical studies to deplete CD38+ cells that include plasma cells and natural killer, or NK, cells which mayallow for applications that improve clinical outcomes in a broad range of immune-mediated diseases. | $95M | Series B | Jan 04, 2024 |  |
| Intract | Intract is the owner and operator of a web3 platform for marketing services. Customer relationship management, growth hacking, and token gating are among the marketing services provided by the organization. Its platform analyzes real users and performs high-ROI marketing campaigns to recruit more like them, allowing firms to sell themselves andattract more customers using blockchain technology. | $3M | Seed | Dec 13, 2023 |  |

10 of 116 investments shown.

## Co-investors
- [Alpha Wave Global](https://shizune.co/investors/profile/alpha-wave-global) — VC Fund, 110 deals together
- [Tiger Global Management](https://shizune.co/investors/profile/tiger-global) — VC Fund, 22 deals together
- [Z47](https://shizune.co/investors/profile/matrix-partners-india) — VC Fund, 17 deals together
- [Peak XV Partners](https://shizune.co/investors/profile/sequoia-india-2) — VC Fund, 16 deals together
- [Accel](https://shizune.co/investors/profile/accel) — VC Fund, 9 deals together
- [SoftBank Vision Fund](https://shizune.co/investors/profile/softbank-vision-fund) — VC Fund, 7 deals together

## Similar investors

### Similar industry
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund
- [British Business Investments](https://shizune.co/investors/profile/british-business-investments) — VC Fund
- [White Star Capital](https://shizune.co/investors/profile/white-star-capital) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Titan Capital](https://shizune.co/investors/profile/titan-capital) — VC Fund
- [Inflection Point Ventures](https://shizune.co/investors/profile/inflection-point-ventures-d275) — VC Fund
- [Blume Ventures](https://shizune.co/investors/profile/blume-ventures) — VC Fund

## Featured in investor lists
- [Hardware VC Funds in India](https://shizune.co/investors/hardware-vc-funds-india)
- [Artificial intelligence VC Funds in India](https://shizune.co/investors/artificial-intelligence-vc-funds-india)
- [Artificial intelligence Investors in India](https://shizune.co/investors/artificial-intelligence-investors-india)
- [Hardware Investors in India](https://shizune.co/investors/hardware-investors-india)
- [Machine Learning VC Funds in India](https://shizune.co/investors/machine-learning-vc-funds-india)
- [Machine Learning Investors in India](https://shizune.co/investors/machine-learning-investors-india)

## FAQ

### What does Alpha Wave Global invest in?

Alpha Wave Global invests primarily in Financial Services, Artificial Intelligence and FinTech startups, most often at Series B and Series A stage. Most of the 116 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Alpha Wave Global's check size?

Alpha Wave Global typically joins rounds of $4.5M–$70M at Series A, $17M–$135M at Series B and $28M–$135M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Alpha Wave Global participates in.

### How do I contact Alpha Wave Global?

Public channels for Alpha Wave Global include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Alpha Wave Global?

The team at Alpha Wave Global includes Chris Dimitropoulos (Managing Director), Mohammad MM (Testing) and Navroz Udwadia (Co-Founder and Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co